Herborium Group Targets Indian Skin Care Market

TEANECK, N.J., Feb. 15, 2012 /PRNewswire/ -- Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com, a Botanical Therapeutics® company, announced today its plan to launch an aggressive marketing campaign targeting sales of its proprietary, all botanical acne treatment -- AcnEase® -- to the most affluent ethnic market in the US that is Asian Indian and Asian Indian Decent population. AcnEase is a perfect match for the Indian market with its rising purchasing power and fashion consciousness combined with preference for natural, herbal based products. Most importantly, AcnEase while proven effective to eliminate symptoms of acne will not discolor or bleach darker complexion; the problem that may result from using many topical products on the market.

"We have hired Mr. Karan Sharma, also a Director of Elite Enterprises LTD of US and Mumbai, whose experience includes 15 years of building vast Ethnic Indian distribution networks in the US and UK to lead our efforts in providing our unique acne treatment to Indian Ethnic markets.  We are very excited about Mr. Sharma joining the Herborium team," stated Dr. Agnes P. Olszewski, CEO of Herborium.

"According to the latest National Census, Asian Indians have the highest Median Family Income in the US ($101,000/year) and the highest rate of any ethnic groups (64.4%) of college degrees. We believe that these demographics, together with our product's unique characteristics and benefits, and Mr. Sharma's expertise provide for powerful revenue and market share drivers in the profitable Indian Ethnic market," added Dr. Olszewski.

"We also treat our entry into Indian Ethnic markets in the US and UK as the first step in a future expansion to Indian market. Indian cosmetic industry is estimated to grow around 22% during 2011-2014," concluded Dr. Olszewski.

About AcnEase®:

AcnEase® is unique all botanical therapeutic® for acne. Over 130 million people are affected by acne in the US and Europe alone. Herborium's AcnEase® results are very impressive, with up to 95% of both females and males seeing significant improvement after the first course of treatment

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: [email protected]

SOURCE Herborium Group, Inc.